Defense industry faces squeeze in looming competitiveness crunch

Article Abstract:

The US defense industry is facing growing pressure in jobs, skills and the ability to innovate as overseas firms are creating software and taking on tasks formerly completed domestically. The National Academy of Sciences (NAS) study has found that the US competitiveness is not under crisis at the moment, but has found an alarming situation evolving in coming years as the indicators for the future are almost all in the wrong direction.

Industry overview

---

Analyst: Big changes afoot in defense industry

Article Abstract:

The director of the Industry Studies Program has stated that big changes occurring in the defense industry are bringing with them new trends that ought to be part of the 2005 Quadrennial Defense Review (QDR). The QDR is an every-four-years, top-to-bottom review of U.S. military posture and strategy done for the president and Congress and the 2005 QDR is expected to be completed early next year.

Industry forecasts

---

Sitting on big backlog, Boeing defense chief sees harder times ahead

Article Abstract:

The Boeing Co.'s Integrated Defense Systems (IDS) business has an industry-leading backlog in excess of $200 billion, or more than two-and-a-half times its revenue. Boeing IDS has restructured its operations to better position the unit for the future so that the cost structure and complexity can be reduced.

Organizational history, Company restructuring/company reorganization, Reorganization and restructuring, Company organization, Boeing Co. Boeing Integrated Defense Systems

Similar abstracts:

• Abstracts: Cebrowski: Major defense contractors should face new competition. Bush names Krieg as permanent Pentagon procurement chief
• Abstracts: How the industry operates. Operating environment ahead
• Abstracts: The changing face of Euro payments. Getting comfortable with growth
• Abstracts: Antibiotics-an investment worth making? Genetech faces the consequences of growth
• Abstracts: China syndrome - a regulatory framework in meltdown? Lack of private financing hobbles emerging biotech regions

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.